ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CON vs CDNA // NET PROFIT MARGIN

Concentra Group Holdings Parent Inc. (NYSE) VS. CareDx Inc. (NASDAQ) • 15-METRIC TALLY: CON 7 — CDNA 4
▲ NET PROFIT MARGIN LEADER: CON
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CON VS. CDNA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CON CDNA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 19.70% -8.20% +27.90 CON /roic <GO>
EV/EBITDA & P/E Valuation 15.4x — — TIE /valuation <GO>
Free Cash Flow Yield 3.75% 0.67% +3.08 CON /fcf-yield <GO>
Operating Margin 15.40% -8.10% +23.50 CON /operating-margins <GO>
Net Profit Margin ACTIVE 7.70% -5.60% +13.30 CON /net-margins <GO>
Revenue Growth (YoY) 13.90% 13.80% +0.10 CON /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.61% 0.00% +0.61 CON /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.53 19.22 -16.69 CDNA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.7 67.4 -5.70 CDNA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.00 1.06 -0.06 CDNA /macro-sensitivity <GO>
Forward P/E Multiple 26.5x 21.0x +5.50 CDNA /forward-pe <GO>
Enterprise Scale & Market Cap $5.15B $4.59B $556.4M CON /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CON REV CDNA REV CON GROSS % CDNA GROSS % CON FCF CDNA FCF
FY 2025 $2.16B $379.8M — — $197.1M $24.9M
FY 2024 $1.90B $333.8M — — $210.3M $23.0M
FY 2023 $1.84B $280.3M — — $151.6M -$31.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CON // BETA 1.00
CDNA // BETA 1.06